Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel Meeting on Device-Based Therapies for hypertension.

MedStar author(s):
Citation: Cardiovascular Revascularization Medicine. 20(10):891-896, 2019 Oct.PMID: 31447315Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Autonomic Denervation/is [Instrumentation] | *Blood Pressure | *Catheter Ablation/is [Instrumentation] | *Device Approval | *Hypertension/th [Therapy] | *Kidney/bs [Blood Supply] | *Renal Artery/ir [Innervation] | *United States Food and Drug Administration | Antihypertensive Agents/tu [Therapeutic Use] | Autonomic Denervation/ae [Adverse Effects] | Blood Pressure/de [Drug Effects] | Catheter Ablation/ae [Adverse Effects] | Drug Resistance | Equipment Design | Equipment Safety | Humans | Hypertension/di [Diagnosis] | Hypertension/pp [Physiopathology] | Patient Safety | Risk Assessment | Risk Factors | Treatment Outcome | United StatesYear: 2019Local holdings: Available in print through MWHC library: 2002 - presentISSN:
  • 1878-0938
Name of journal: Cardiovascular revascularization medicine : including molecular interventionsAll authors: Chen Y, Dan K, Khalid N, Rogers T, Shlofmitz E, Torguson R, Waksman R, Weintraub WSOriginally published: Cardiovascular Revascularization Medicine. 2019 Jul 17Fiscal year: FY2020Digital Object Identifier: Date added to catalog: 2019-10-10
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 31447315 Available 31447315

Available in print through MWHC library: 2002 - present


Powered by Koha